Patents by Inventor Elie Abou-Khalil

Elie Abou-Khalil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE SYNTHESIS OF COMPOUNDS WHICH ABSORB ULTRAVIOLET RADIATION IN FLOW CONDITIONS AND FORMULATIONS COMPRISING SAME
    Publication number: 20230159476
    Abstract: The present invention generally relates to a chemical process under flow conditions for manufacturing compounds which absorb ultraviolet (UV) radiation and protect biological materials as well as non-biological materials from damaging exposure to UV radiation. The present invention further includes formulations and compositions comprising such compounds for use in absorbing UV radiation, as well as methods for protecting biological materials as well as non-biological materials from damaging exposure to UV radiation.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 25, 2023
    Inventors: Elie Abou KHALIL, Renan CARIOU, Shawn PARISIEN-COLLETTE, Julie CHANTEAU, Sophie LANGIS-BARSETTI
  • Imino compounds as protecting agents against ultraviolet radiations
    Patent number: 9487474
    Abstract: The present invention relates to compounds having the general Formula I: which absorb UV radiations and protect biological materials as well as non-biological materials from damaging exposure to UV radiations. The present invention also relates to formulations and compositions comprising such compounds for use in absorbing UV radiations and in protecting biological materials as well as non-biological materials against UV radiations.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: November 8, 2016
    Assignee: Elkimia, Inc.
    Inventors: Elie Abou-Khalil, Stephane Raeppel, Franck Raeppel
  • IMINO COMPOUNDS AS PROTECTING AGENTS AGAINTS ULTRAVIOLET RADIATIONS
    Publication number: 20150152046
    Abstract: The present invention relates to compounds having the general Formula I: which absorb UV radiations and protect biological materials as well as non-biological materials from damaging exposure to UV radiations. The present invention also relates to formulations and compositions comprising such compounds for use in absorbing UV radiations and in protecting biological materials as well as non-biological materials against UV radiations.
    Type: Application
    Filed: May 31, 2013
    Publication date: June 4, 2015
    Inventors: Elie Abou-Khalil, Stephane Raeppel, Franck Raeppel
  • Inhibitors of histone deacetylase
    Patent number: 6541661
    Abstract: The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: April 1, 2003
    Assignee: MethylGene, Inc.
    Inventors: Daniel Delorme, Rejean Ruel, Rico Lavoie, Carl Thibault, Elie Abou-Khalil
  • Inhibitors of histone deacetylase
    Patent number: RE39850
    Abstract: The invention relates to the inhibition of histone deactylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: September 18, 2007
    Assignee: Methylgene, Inc.
    Inventors: Daniel Delorme, Rico Lavoie, Carl Thibault, Elie Abou-Khalil, Rejean Ruel
  • Inhibitors of histone deacetylase
    Patent number: RE43343
    Abstract: The invention relates to the inhibition of histone deactylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: May 1, 2012
    Assignee: Methylgene Inc.
    Inventors: Daniel Delorme, Rejean Ruel, Rico Lavoie, Carl Thibault, Elie Abou-Khalil